Cardiac MRI in Muscular Dystrophy: An Overview and Future Directions

Physical Medicine and Rehabilitation Clinics of North America

Volumn 23, Issue 1, 2012, Pages 123-132

  Otto, Randolph K ^a   Ferguson, Mark R ^a   Friedman, Seth D ^a  

^a SEATTLE CHILDREN S HOSPITAL   (United States)

Author keywords

Becker muscular dystrophy; Cardiac; Duchenne muscular dystrophy; MRI; Muscular dystrophy; X linked dilated cardiomyopathy

Indexed keywords

BIOLOGICAL MARKER; CARVEDILOL; CORTICOSTEROID; GADOLINIUM;

BECKER MUSCULAR DYSTROPHY; CARDIAC IMAGING; CARDIOMYOPATHY; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL FEATURE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DUCHENNE MUSCULAR DYSTROPHY; ECHOCARDIOGRAPHY; HUMAN; IMAGE PROCESSING; LONGITUDINAL STUDY; MUSCULAR DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION;

CONTRAST MEDIA; HEART; HEART DISEASES; HETEROZYGOTE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MUSCULAR DYSTROPHIES;

EID: 84855736885     PISSN: 10479651     EISSN: 15581381     Source Type: Journal    
DOI: 10.1016/j.pmr.2011.11.008     Document Type: Review

References (40)

1. Hermans M.C., Pinto Y.M., Merkies I.S., et al. Hereditary muscular dystrophies and the heart. Neuromuscul Disord 2010, 20:479-492.
2. Hsu D.T. Cardiac manifestations of neuromuscular disorders in children. Paediatr Respir Rev 2010, 11:35-38.
3. Shathasivam T., Kislinger T., Gramolini A.O. Genes, proteins and complexes: the multifaceted nature of FHL family proteins in diverse tissues. JCell Mol Med 2010, 14:2702-2720.
4. Markham L.W., Kinnett K., Wong B.L., et al. Corticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophy. Neuromuscul Disord 2008, 18:365-370.
5. Matsumura T., Tamura T., Kuru S., et al. Carvedilol can prevent cardiac events in Duchenne muscular dystrophy. Intern Med 2010, 49:1357-1363.
6. Paterson D.I., OMeara E., Chow B.J., et al. Recent advances in cardiac imaging for patients with heart failure. Curr Opin Cardiol 2011, 26:132-143.
7. Korosoglou G., Osman N.F., Dengler T.J., et al. Strain-encoded cardiac magnetic resonance for the evaluation of chronic allograft vasculopathy in transplant recipients. Am J Transplant 2009, 9:2587-2596.
8. Zerhouni E.A., Parish D.M., Rogers W.J., et al. Human heart: tagging with MR imaging-a method for noninvasive assessment of myocardial motion. Radiology 1988, 169:59-63.
9. Magri D., Sciomer S., Fedele F., et al. Early impairment of myocardial function in young patients with beta-thalassemia major. Eur J Haematol 2008, 80:515-522.
10. Fernandes V.R., Edvardsen T., Rosen B.D., et al. The influence of left ventricular size and global function on regional myocardial contraction and relaxation in an adult population free of cardiovascular disease: a tagged CMR study of the MESA cohort. JCardiovasc Magn Reson 2007, 9:921-930.
11. Hor K.N., Gottliebson W.M., Carson C., et al. Comparison of magnetic resonance feature tracking for strain calculation with harmonic phase imaging analysis. JACC Cardiovasc Imaging 2010, 3:144-151.
12. Kuijer J.P., Hofman M.B., Zwanenburg J.J., et al. DENSE and HARP: two views on the same technique of phase-based strain imaging. JMagn Reson Imaging 2006, 24:1432-1438.
13. Emery A.E. Population frequencies of inherited neuromuscular diseases-a world survey. Neuromuscul Disord 1991, 1:19-29.
14. Laing N.G., Davis M.R., Bayley K., et al. Molecular diagnosis of Duchenne muscular dystrophy: past, present and future in relation to implementing therapies. Clin Biochem Rev 2011, 32:129-134.
15. Hor K.N., Wansapura J., Markham L.W., et al. Circumferential strain analysis identifies strata of cardiomyopathy in Duchenne muscular dystrophy: a cardiac magnetic resonance tagging study. JAm Coll Cardiol 2009, 53:1204-1210.
16. Hor K.N., Wansapura J.P., Al-Khalidi H.R., et al. Presence of mechanical dyssynchrony in Duchenne muscular dystrophy. JCardiovasc Magn Reson 2011, 13:12.
17. Simonetti O.P., Raman S.V. Straining to justify strain measurement. JACC Cardiovasc Imaging 2010, 3:152-154.
18. Ashford M.W. Jr, Liu W., Lin S.J., et al. Occult cardiac contractile dysfunction in dystrophin-deficient children revealed by cardiac magnetic resonance strain imaging. Circulation 2005, 112:2462-2467.
19. Hagenbuch S.C., Gottliebson W.M., Wansapura J., et al. Detection of progressive cardiac dysfunction by serial evaluation of circumferential strain in patients with Duchenne muscular dystrophy. Am J Cardiol 2010, 105:1451-1455.
20. McNally E.M. New approaches in the therapy of cardiomyopathy in muscular dystrophy. Annu Rev Med 2007, 58:75-88.
21. McNally E.M. Duchenne muscular dystrophy: how bad is the heart?. Heart 2008, 94:976-977.
22. McNally E.M., MacLeod H. Therapy insight: cardiovascular complications associated with muscular dystrophies. Nat Clin Pract Cardiovasc Med 2005, 2:301-308.
23. Williams A.R., Trachtenberg B., Velazquez D.L., et al. Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling. Circ Res 2011, 108:792-796.
24. Hopp E., Lunde K., Solheim S., et al. Regional myocardial function after intracoronary bone marrow cell injection in reperfused anterior wall infarction: a cardiovascular magnetic resonance tagging study. JCardiovasc Magn Reson 2011, 13:22.
25. Bilchick K.C., Salerno M., Plitt D., et al. Prevalence and distribution of regional scar in dysfunctional myocardial segments in Duchenne muscular dystrophy. JCardiovasc Magn Reson 2011, 13:20.
26. Yilmaz A., Gdynia H.J., Baccouche H., et al. Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach. JCardiovasc Magn Reson 2008, 10:50.
27. Mavrogeni S., Tzelepis G.E., Athanasopoulos G., et al. Cardiac and sternocleidomastoid muscle involvement in Duchenne muscular dystrophy: an MRI study. Chest 2005, 127:143-148.
28. Finsterer J., Stollberger C. Clinical implications of MRI to assess cardiac and pulmonary function in patients with Duchenne muscular dystrophy. Chest 2010, 138:756-757. [author reply: 757].
29. Mavrogeni S., Papavasiliou A., Spargias K., et al. Myocardial inflammation in Duchenne Muscular Dystrophy as a precipitating factor for heart failure: a prospective study. BMC Neurol 2010, 10:33.
30. Wansapura J.P., Hor K.N., Mazur W., et al. Left ventricular T2 distribution in Duchenne muscular dystrophy. JCardiovasc Magn Reson 2010, 12:14.
31. Ghugre N.R., Enriquez C.M., Coates T.D., et al. Improved R2* measurements in myocardial iron overload. JMagn Reson Imaging 2006, 23:9-16.
32. Puchalski M.D., Williams R.V., Askovich B., et al. Late gadolinium enhancement: precursor to cardiomyopathy in Duchenne muscular dystrophy?. Int J Cardiovasc Imaging 2009, 25:57-63.
33. Silva M.C., Meira Z.M., Gurgel Giannetti J., et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy. JAm Coll Cardiol 2007, 49:1874-1879.
34. Politano L., Nigro V., Nigro G., et al. Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies. JAMA 1996, 275:1335-1338.
35. Barison A., Aquaro G.D., Passino C., et al. Cardiac magnetic resonance imaging and management of dilated cardiomyopathy in a Duchenne muscular dystrophy manifesting carrier. JNeurol 2009, 256:283-284.
36. Walcher T., Kunze M., Steinbach P., et al. Cardiac involvement in a female carrier of Duchenne muscular dystrophy. Int J Cardiol 2010, 138:302-305.
37. Yilmaz A., Gdynia H.J., Ludolph A.C., et al. Images in cardiovascular medicine. Cardiomyopathy in a Duchenne muscular dystrophy carrier and her diseased son: similar pattern revealed by cardiovascular MRI. Circulation 2010, 121:e237-e239.
38. Finsterer J., Stollberger C., Avanzini M., et al. Late gadolinium enhancement as subclinical myocardial involvement in a manifesting Duchenne carrier. Int J Cardiol 2011, 146:231-232.
39. Dubowitz V. Therapeutic efforts in Duchenne muscular dystrophy; the need for a common language between basic scientists and clinicians. Neuromuscul Disord 2004, 14:451-455.
40. Yokota T., Pistilli E., Duddy W., et al. Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy. Expert Opin Biol Ther 2007, 7:831-842.